Association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma in the Phase III CELESTIAL trial

Strasser, S.Abou-Alfa, G.Meyer, T.Cheng, A.Cicin, I.Bolondi, L.Klumpen, H.2024-06-122024-06-1220190815-93191440-1746https://hdl.handle.net/20.500.14551/26814[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma in the Phase III CELESTIAL trialConference Object343334Q2WOS:000483843100049